News
PAHC
25.77
+2.30%
0.58
ZBH Stock Hurt by Margin Concerns and Difficult Solvency
NASDAQ · 9h ago
Weekly Report: what happened at PAHC last week (0210-0214)?
Weekly Report · 14h ago
4 PEG-Based Value Stocks to Shield Your Portfolio From Trade War
NASDAQ · 3d ago
Best Momentum Stocks to Buy for February 14th
NASDAQ · 3d ago
4 Stocks Trading Near 52-Week High With More Upside Potential
NASDAQ · 3d ago
Is Now the Right Time to Hold on to Charles River Stock?
NASDAQ · 3d ago
New Strong Buy Stocks for February 14th
NASDAQ · 3d ago
Best Value Stocks to Buy for February 14th
Barchart · 3d ago
Best Income Stocks to Buy for February 14th
Barchart · 3d ago
Value, Growth and Momentum: DAN and PAHC Stocks Have it All
NASDAQ · 4d ago
HOLX's New Offerings Likely to Revive Stock Amid Macro Woes
NASDAQ · 4d ago
TMO Stock Set to Gain From The Launch of New Spatial Imaging System
NASDAQ · 4d ago
Zoetis forecasts 2025 profit, revenue below estimates; shares fall
Reuters · 4d ago
Phibro Animal Health Is Cruising With Its Recent Zoetis Acquisition
Seeking Alpha · 4d ago
Here's Why You Should Retain HOLX Stock in Your Portfolio Now
NASDAQ · 4d ago
ALGN Stock Gains on the Launch of Invisalign Palatal Expander in Turkey
NASDAQ · 4d ago
Should You Add Penumbra Stock to Your Portfolio Right Now?
NASDAQ · 5d ago
Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain?
NASDAQ · 6d ago
Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes"
NASDAQ · 02/10 17:45
Phibro Animal Health Is Maintained at Underweight by Barclays
Dow Jones · 02/10 12:39
More
Webull provides a variety of real-time PAHC stock news. You can receive the latest news about Phibro Animal through multiple platforms. This information may help you make smarter investment decisions.
About PAHC
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.